The cold chain is a headache for the delivery of many modern vaccines, especially RNA-based ones. Until now, they required storage at ultra-low temperatures, making their logistics to remote regions a real challenge. Researchers from MIT have found a way to make these fragile preparations heat-stable, using artificial intelligence.
Using a machine learning algorithm, scientists were able to optimize the composition of lipid nanoparticles that protect RNA vaccines. The result is impressive: new formulations maintain stability at room temperature for up to a year, and at temperatures around 37 degrees Celsius for up to two months. This breaks one of the main limitations of RNA technologies.
Experiments on mice showed that vaccines that underwent such "thermal stress" elicited an immune response as strong as their "cold" counterparts. AI not only accelerated the process of finding the right formula, reducing the number of necessary experiments from months to weeks, but also allowed working with FDA-approved components, bringing the technology closer to practical application.
Now, vaccine distribution can become simpler and cheaper, and the vaccines themselves more accessible. This opens the door for new delivery methods, such as microneedle patches, which could be more convenient and effective than traditional injections. Essentially, we are seeing how AI helps overcome physical barriers to medical innovations, making them more versatile and practical for the real world.